Telesis Bio, Inc.

NASDAQ:TBIO

2.93 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1.553.446.9775.5648.6526.3169.4696.6755.6555.6363.0782.7862.8522.3271.9371.6351.6171.3873.891.2661.1741.4741.1820.238000000
Cost of Revenue 3.1553.1692.8812.5672.9592.8053.0233.0162.9432.8582.1961.6241.8991.0251.0180.7390.620.574000000000000
Gross Profit -1.6050.2714.0962.9975.6933.5116.4463.6592.7122.7780.8821.1620.9531.3020.9190.8960.9970.8133.891.2661.1741.4741.1820.238000000
Gross Profit Ratio -1.0350.0790.5870.5390.6580.5560.6810.5480.480.4930.2870.4170.3340.560.4740.5480.6170.586111111000000
Reseach & Development Expenses 2.472.9253.0164.1194.5875.1214.1395.8167.1246.3815.3313.5932.7462.8782.6622.3451.9551.96325.02617.29516.62517.42317.1712.93315.21912.70212.79911.09713.5069.621
General & Administrative Expenses 5.5075.3673.5686.2565.7125.5545.515.2615.5615.7994.6334.0553.1492.4131.2540.990.741.1467.3486.8817.856.5545.885.9575.9914.7794.6053.6073.1252.973
Selling & Marketing Expenses 1.6981.6753.6042.7433.363.8074.6813.8334.5143.4613.0152.9552.632.2752.1731.8611.5981.299000000000000
SG&A 6.3995.8677.1728.9999.0729.36110.1919.09410.0759.267.6487.015.7794.6883.4272.8512.3382.4457.3486.8817.856.5545.885.9575.9914.7794.6053.6073.1252.973
Other Expenses -0.015-0.125-0.1110.02-0.003-0.036-0.0080.006-0.012-0.012-0.033-0.0130.003-0.0190.003-0.006-0.0710000000000000
Operating Expenses 8.8698.79210.18813.11813.65914.48214.3314.9117.19915.64112.97910.6038.5257.5666.0895.1964.2934.40832.37424.17624.47523.97723.0518.8921.2117.48117.40414.70416.63112.594
Operating Income -10.474-8.521-6.092-10.121-7.966-10.971-7.884-11.251-14.487-12.863-12.097-9.441-7.572-6.264-5.17-4.3-3.296-3.595-31.036-21.227-27.832-33.684-6.476-45.17-29.003-22.312-24.552-20.764-18.803-14.805
Operating Income Ratio -6.757-2.477-0.873-1.819-0.921-1.737-0.833-1.686-2.562-2.282-3.93-3.389-2.655-2.692-2.669-2.63-2.038-2.592-7.978-16.767-23.707-22.852-5.479-189.79000000
Total Other Income Expenses Net -1.086-0.114-11.5920.1870.016-0.145-0.242-1.057-0.338-0.325-0.0220.002-1.248-0.933-0.2220.006-0.645-0.093000000000000
Income Before Tax -11.56-8.635-17.684-10.617-8.283-11.116-8.126-12.308-14.825-13.188-12.487-9.82-9.199-7.438-5.58-4.463-4.082-3.88-31.036-21.227-27.832-33.684-6.476-45.17-29.003-22.312-24.552-20.764-18.803-14.805
Income Before Tax Ratio -7.458-2.51-2.535-1.908-0.957-1.76-0.858-1.844-2.622-2.34-4.057-3.525-3.225-3.196-2.881-2.73-2.524-2.797-7.978-16.767-23.707-22.852-5.479-189.79000000
Income Tax Expense 0.0010.0020.0030.0140.0040.0030.0060.0060.0060.0060.0040.0040.0020.0040.0030.002-0.141-0.1921.7350.9460.894-0.486-0.439-2.524-1.5-1.103-8.461-2.299-0.87-0.851
Net Income -12.585-8.637-17.687-10.631-8.287-11.119-8.132-12.314-14.831-13.194-12.491-9.824-9.201-7.442-5.583-4.465-4.082-3.88-31.036-21.227-27.832-33.198-6.037-42.646-27.503-21.209-16.091-18.465-17.933-13.954
Net Income Ratio -8.119-2.511-2.535-1.911-0.958-1.76-0.859-1.845-2.623-2.341-4.058-3.526-3.226-3.198-2.882-2.731-2.524-2.797-7.978-16.767-23.707-22.522-5.107-179.185000000
EPS -0.42-0.29-0.59-0.35-0.28-0.37-0.28-0.42-0.5-0.45-0.43-0.34-0.32-0.26-0.22-0.21-0.19-0.18-0.52-0.41-0.57-0.74-0.13-0.97-0.7-0.61-0.46-0.53-0.51-0.4
EPS Diluted -0.42-0.29-0.59-0.35-0.28-0.37-0.28-0.42-0.5-0.45-0.43-0.34-0.32-0.26-0.22-0.21-0.19-0.18-0.52-0.41-0.57-0.74-0.13-0.97-0.7-0.61-0.46-0.53-0.51-0.4
EBITDA -9.668-7.346-4.941-9.247-7.969-11.007-7.892-11.245-13.852-12.282-11.655-9.084-7.199-5.924-4.807-3.945-3.002-3.224-29.255-20.236-26.897-32.659-5.558-44.694-28.092-21.776-24.101-20.37-18.254-14.614
EBITDA Ratio -6.237-2.135-0.708-1.662-0.921-1.743-0.833-1.685-2.45-2.179-3.787-3.261-2.524-2.546-2.482-2.413-1.857-2.324-7.521-15.984-22.911-22.157-4.702-187.79000000